FMP
Aarti Industries Limited
AARTIIND.NS
NSE
Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, pigments, paints, printing inks, rubber chemicals, resins, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was incorporated in 1984 and is headquartered in Mumbai, India.
739.4 INR
-0.1 (-0.01352%)
EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income) EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company (1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments), (2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill) (3*) collections of assets (by ignoring depreciation of assets) (4*) different takeover histories (by ignoring amortization often stemming from goodwill)
